MedTrace Logo

Eye Movement Desensitization and Reprocessing (EMDR) for Police Personnel

NCT05171868 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-05-17

No results posted yet for this study

Summary

Objectives:

1. To examine the feasibility of Eye Movement Desensitization and Reprocessing (EMDR) as an intervention to reduce psychological trauma and stress amongst police officers in Pakistan.
2. To test whether reducing stress and psychological trauma reduces suicidal ideation in police officers.
3. To explore participants' experiences with EMDR Intervention.

Study design and setting:

The study will be a mixed-method feasibility randomized controlled trial of EMDR as an intervention in treating symptoms such as stress, trauma and suicidal ideation in police officers. The study will be conducted in five major cities in Pakistan: Rawalpindi, Karachi, Peshawar, Quetta, and Lahore.

Sample size:

A total of N=80 eligible police officers will be recruited and randomized in the study.

Conditions

Interventions

BEHAVIORAL

Eye Movement Desensitization and Reprocessing (EMDR)

Each participant in the intervention group will receive 8 individual, weekly EMDR sessions over 8 weeks. Each session will take approximately 60-90 minutes. The sessions will be delivered at a place convenient to the participant. Trained EMDR therapists will deliver the intervention.

Sponsors & Collaborators

  • University of Manchester

    collaborator OTHER

  • Pakistan Institute of Living and Learning

    lead OTHER

Principal Investigators

  • Nusrat Husain · University of Manchester

  • Nasim Chahudhry · Pakistan Institute of Living and Learning

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-20
Primary Completion
2024-12-30
Completion
2025-06-30

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05171868 on ClinicalTrials.gov